Panel Discussion: What, When & How? Pursuing Combination Therapy to Improve Durable Efficacy & Decrease Viral Breakthrough

Time: 8:30 am
day: Day One


• Sequencing multiple mechanisms of action acting on immune and viral targets to optimize therapeutic effect

• Identifying effective combinations to achieve treatment with finite durations

• Measuring toxicity and adverse events in combination therapy for HBV